Open Access

[Retracted] Galectin‑3 blockade suppresses the growth of cetuximab‑resistant human oral squamous cell carcinoma

  • Authors:
    • Peng Yin
    • Shuanlong Cui
    • Xiangling Liao
    • Xiaoguang Yao
  • View Affiliations

  • Published online on: July 1, 2024     https://doi.org/10.3892/mmr.2024.13275
  • Article Number: 152
  • Copyright : © Yin et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY 4.0].

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Article

Related Articles

Journal Cover

September-2024
Volume 30 Issue 3

Print ISSN: 1791-2997
Online ISSN:1791-3004

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Yin P, Cui S, Liao X and Yao X: [Retracted] Galectin‑3 blockade suppresses the growth of cetuximab‑resistant human oral squamous cell carcinoma. Mol Med Rep 30: 152, 2024.
APA
Yin, P., Cui, S., Liao, X., & Yao, X. (2024). [Retracted] Galectin‑3 blockade suppresses the growth of cetuximab‑resistant human oral squamous cell carcinoma. Molecular Medicine Reports, 30, 152. https://doi.org/10.3892/mmr.2024.13275
MLA
Yin, P., Cui, S., Liao, X., Yao, X."[Retracted] Galectin‑3 blockade suppresses the growth of cetuximab‑resistant human oral squamous cell carcinoma". Molecular Medicine Reports 30.3 (2024): 152.
Chicago
Yin, P., Cui, S., Liao, X., Yao, X."[Retracted] Galectin‑3 blockade suppresses the growth of cetuximab‑resistant human oral squamous cell carcinoma". Molecular Medicine Reports 30, no. 3 (2024): 152. https://doi.org/10.3892/mmr.2024.13275